BRPI0608796B8 - método para a preparação de um extrato de planta compreendendo bacuquiol - Google Patents
método para a preparação de um extrato de planta compreendendo bacuquiolInfo
- Publication number
- BRPI0608796B8 BRPI0608796B8 BRPI0608796A BRPI0608796A BRPI0608796B8 BR PI0608796 B8 BRPI0608796 B8 BR PI0608796B8 BR PI0608796 A BRPI0608796 A BR PI0608796A BR PI0608796 A BRPI0608796 A BR PI0608796A BR PI0608796 B8 BRPI0608796 B8 BR PI0608796B8
- Authority
- BR
- Brazil
- Prior art keywords
- compositions
- methods
- bacuquiol
- present
- preparing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 5
- 239000000419 plant extract Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 6
- 239000012535 impurity Substances 0.000 abstract 2
- 102000003820 Lipoxygenases Human genes 0.000 abstract 1
- 108090000128 Lipoxygenases Proteins 0.000 abstract 1
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 abstract 1
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- CRMBVHJMQTYDMJ-QZTJIDSGSA-N furanocoumarin Natural products CC(C)OC(C)(C)[C@H](O)COc1c2C=CC(=O)Oc2c(OC[C@@H](O)C(=C)C)c3occc13 CRMBVHJMQTYDMJ-QZTJIDSGSA-N 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000004968 inflammatory condition Effects 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 230000000813 microbial effect Effects 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/487—Psoralea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Cardiology (AREA)
- Reproductive Health (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US67933705P | 2005-05-09 | 2005-05-09 | |
US60/679,337 | 2005-05-09 | ||
PCT/US2006/018006 WO2006122160A2 (en) | 2005-05-09 | 2006-05-09 | Compositions of bakuchiol and methods of making the same |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0608796A2 BRPI0608796A2 (pt) | 2010-01-26 |
BRPI0608796B1 BRPI0608796B1 (pt) | 2019-04-30 |
BRPI0608796B8 true BRPI0608796B8 (pt) | 2021-05-25 |
Family
ID=37397255
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0608796A BRPI0608796B8 (pt) | 2005-05-09 | 2006-05-09 | método para a preparação de um extrato de planta compreendendo bacuquiol |
Country Status (8)
Country | Link |
---|---|
US (4) | US20060251749A1 (pt) |
EP (1) | EP1881839A4 (pt) |
JP (1) | JP5443754B2 (pt) |
KR (3) | KR101431060B1 (pt) |
CN (1) | CN101217968B (pt) |
BR (1) | BRPI0608796B8 (pt) |
HK (1) | HK1120743A1 (pt) |
WO (1) | WO2006122160A2 (pt) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101217968B (zh) | 2005-05-09 | 2014-11-26 | 尤尼根公司 | 补骨脂酚的组合物及其制备方法 |
CN101088498B (zh) * | 2006-06-13 | 2011-09-07 | 和泓生物技术(上海)有限公司 | 补骨脂酚类化合物的应用 |
CN101224201B (zh) * | 2007-01-18 | 2011-10-05 | 和泓生物技术(上海)有限公司 | 多巴胺转运蛋白和去甲肾上腺素转运蛋白双重抑制剂的应用 |
US20080286217A1 (en) * | 2007-05-14 | 2008-11-20 | Chaudhuri Ratan K | Sunscreen compositions and methods |
ES2689715T3 (es) * | 2007-05-14 | 2018-11-15 | Sytheon Ltd. | Composiciones para tratamiento de la piel y métodos |
US8859021B2 (en) * | 2007-05-14 | 2014-10-14 | Sytheon | Skin appearance through gene manipulation |
US8529967B2 (en) * | 2007-05-14 | 2013-09-10 | Sytheon Ltd. | Sunscreen compositions and methods |
CN101406513B (zh) * | 2008-12-03 | 2011-04-27 | 天津中医药大学 | 补骨脂提取物、含有它的药物组合物及其制备方法和用途 |
KR101144197B1 (ko) * | 2009-03-31 | 2012-05-11 | 전남대학교산학협력단 | 신생혈관형성 억제제 및 이를 이용한 천연산물 항비만제 |
JP5723010B2 (ja) * | 2010-08-27 | 2015-05-27 | コリア・インスティテュート・オブ・サイエンス・アンド・テクノロジー | 認知症の予防または治療用組成物 |
DE102010062611A1 (de) * | 2010-12-08 | 2012-06-14 | Henkel Ag & Co. Kgaa | Mund- und Zahnpflege- und -reinigungsmittel mit gesteigerter antibakterieller Wirkung II |
DE102010062610A1 (de) * | 2010-12-08 | 2012-06-14 | Henkel Ag & Co. Kgaa | Mund- und Zahnpflege- und -reinigungsmittel mit gesteigerter antibakterieller Wirkung I |
WO2012105990A1 (en) * | 2011-02-02 | 2012-08-09 | Unigen, Inc. | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation |
US11253486B2 (en) * | 2011-02-02 | 2022-02-22 | Unigen, Inc. | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation |
WO2012106551A1 (en) * | 2011-02-02 | 2012-08-09 | Unigen, Inc. | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation |
FR2981275B1 (fr) * | 2011-10-18 | 2015-03-20 | Jean Noel Thorel | Composition a base de meroterpene destinee aux peaux grasses, a tendance acneique ou atteintes d'acne |
MX2014004422A (es) * | 2011-10-28 | 2014-06-23 | Kimberly Clark Co | Formulacion esporicida incluyendo extractos botanicos/ingredientes derivados de botanicos. |
AU2011379777B2 (en) | 2011-10-28 | 2016-03-17 | Kimberly-Clark Worldwide, Inc. | Sporicidal formulation including amine oxide surfactant and a mixture of oxidants |
KR102002997B1 (ko) * | 2011-11-03 | 2019-07-25 | (주)아모레퍼시픽 | 탁시폴린 배당체를 유효성분으로 함유하는 화장료 조성물 및 작약 추출물의 추출방법 |
BE1020496A3 (fr) * | 2012-02-10 | 2013-11-05 | Ovogenics Sa | Composition anti-inflammatoire pour moduler la reponse cellulaire des neutrophiles et des eosinophiles. |
CN102875562B (zh) * | 2012-07-27 | 2015-04-29 | 天津中医药大学 | 制备补骨脂素和异补骨脂素或包含它们的提取物的方法 |
WO2014167584A2 (en) * | 2013-04-10 | 2014-10-16 | Rupak Enterprises (P) Limited | Herbal compositions for treating pain and skin disorders |
WO2014204853A1 (en) * | 2013-06-19 | 2014-12-24 | Access Business Group International Llc | Plant-based inhibitors of ketohexokinase for the support of weight management |
KR101423005B1 (ko) | 2013-10-17 | 2014-07-28 | 강윤식 | 장 세정용 조성물 |
CN105267293B (zh) * | 2014-07-24 | 2018-11-02 | 中国科学院大连化学物理研究所 | 补骨脂提取物或其单体成分制备人羧酸酯酶抑制剂的应用 |
CN105315295A (zh) * | 2015-04-16 | 2016-02-10 | 霍秀菊 | 一种从补骨脂中分离纯化补骨脂素和异补骨脂素的方法 |
KR101725327B1 (ko) | 2015-08-20 | 2017-04-10 | 숙명여자대학교 산학협력단 | 바쿠치올을 유효성분으로 포함하는 근육위축증 예방 또는 치료용 약학적 조성물 |
CN105061197A (zh) * | 2015-08-28 | 2015-11-18 | 林天样 | 一种新的三萜化合物及其制备方法和医药用途 |
WO2017047769A1 (ja) * | 2015-09-17 | 2017-03-23 | 国立大学法人富山大学 | トール様受容体7またはトール様受容体9の活性化阻害剤 |
US11510885B2 (en) * | 2019-12-02 | 2022-11-29 | Sytheon Ltd. | Compositions and methods for regulating the endocannabinoid system |
KR102142464B1 (ko) * | 2020-02-18 | 2020-08-10 | (주)아모레퍼시픽 | 바쿠치올을 포함하는 피부 장벽 강화 또는 보습용 조성물 |
CN113041399A (zh) * | 2021-03-19 | 2021-06-29 | 温州医科大学附属第二医院(温州医科大学附属育英儿童医院) | 一种可缓释pso的杂化多层膜及其制备方法 |
CN115590848A (zh) * | 2021-06-28 | 2023-01-13 | 上海中医药大学(Cn) | 补骨脂有效成分治疗雄激素依赖性疾病的用途 |
NL2031273B1 (en) * | 2022-03-04 | 2023-09-11 | Sestina Bio Llc | Bioproduction of bakuchiol |
US20230340448A1 (en) * | 2022-03-04 | 2023-10-26 | Inscripta, Inc. | Engineered enzymes and bioproduction of bakuchiol |
KR20240067734A (ko) | 2022-11-09 | 2024-05-17 | 원광대학교산학협력단 | 치주질환 치료, 개선 및 예방용 온도감응성 하이드로겔 조성물 및 이의 제조방법 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3417234A (en) * | 1962-06-21 | 1968-12-17 | Svenska Dataregister Ab | Record reading apparatus and method |
US3553236A (en) * | 1968-12-06 | 1971-01-05 | Franco Indian Pharmaceuticals | Psoralene and isopsoralene, process for their isolation and separation |
DE1900435C3 (de) * | 1969-01-04 | 1974-02-07 | Franco-Indian Pharmacauticals Private Ltd., Bombay (Indien) | Verfahren zur Isolierung und Trennung von Psoralen und Isopsoralen |
DE3417234A1 (de) * | 1984-05-10 | 1985-11-14 | Rudolf V. Dr.rer.nat Dipl.-Chem. 5024 Pulheim Noronha | Hautpflegemittel enthaltend eine kombination von bakuchiol und pyridinaldehyd |
ZA954785B (en) * | 1994-06-16 | 1996-02-08 | Yamanouchi Pharma Co Ltd | Crude drug-containing feed |
US6054584A (en) * | 1996-11-19 | 2000-04-25 | The Board Of Regents Of The University And Community College System Of Neveda | Process for extracting and purifying morphine from opium |
JP3900388B2 (ja) | 1997-08-28 | 2007-04-04 | 丸善製薬株式会社 | 美白剤および美白化粧料 |
KR20000007648A (ko) * | 1998-07-06 | 2000-02-07 | 서경배 | !보골지 추출물 및/또는 바쿠치올을 유효성분으로 하는 시클로옥시게나제-2 저해제 및 보골지추출물 및/또는 바쿠치올을 함유하는 항염증 화장료 |
FR2784294B1 (fr) | 1998-10-12 | 2000-11-17 | Oreal | Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique |
US6878381B2 (en) * | 1999-03-22 | 2005-04-12 | Pfizer, Inc | Resorcinol composition |
JP2000327581A (ja) * | 1999-05-19 | 2000-11-28 | Higashimaru Shoyu Co Ltd | 口腔殺菌用組成物 |
US6350476B1 (en) * | 2000-05-22 | 2002-02-26 | Shanxi Zhengzhon Pharmaceutical Co., Ltd. | Herbal chinese joint complex |
US6750248B2 (en) * | 2001-11-09 | 2004-06-15 | National University Of Singapore | Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof |
US20040043089A1 (en) * | 2002-09-04 | 2004-03-04 | Rabie A-Bakr M | Buguzhi agent and composition and methods of preparing and administering the same |
US7320797B2 (en) * | 2003-08-29 | 2008-01-22 | Bioderm Research | Antiaging cosmetic delivery systems |
TWI298634B (en) * | 2004-05-14 | 2008-07-11 | Sinphar Pharmaceutical Co Ltd | Pharmaceutical composition containing bakuchiol for treating woman osteoporosis |
CN101217968B (zh) | 2005-05-09 | 2014-11-26 | 尤尼根公司 | 补骨脂酚的组合物及其制备方法 |
US20080286217A1 (en) * | 2007-05-14 | 2008-11-20 | Chaudhuri Ratan K | Sunscreen compositions and methods |
ES2689715T3 (es) | 2007-05-14 | 2018-11-15 | Sytheon Ltd. | Composiciones para tratamiento de la piel y métodos |
US9676696B2 (en) * | 2009-01-29 | 2017-06-13 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using skin and/or hair care actives |
WO2012106551A1 (en) * | 2011-02-02 | 2012-08-09 | Unigen, Inc. | Bakuchiol compositions for treatment of post inflammatory hyperpigmentation |
-
2006
- 2006-05-09 CN CN200680024989.3A patent/CN101217968B/zh active Active
- 2006-05-09 BR BRPI0608796A patent/BRPI0608796B8/pt active IP Right Grant
- 2006-05-09 JP JP2008511297A patent/JP5443754B2/ja active Active
- 2006-05-09 KR KR1020077028470A patent/KR101431060B1/ko active IP Right Grant
- 2006-05-09 KR KR1020167011980A patent/KR101802415B1/ko active IP Right Grant
- 2006-05-09 EP EP06759454A patent/EP1881839A4/en not_active Withdrawn
- 2006-05-09 WO PCT/US2006/018006 patent/WO2006122160A2/en active Application Filing
- 2006-05-09 KR KR1020137029277A patent/KR20130125411A/ko active Search and Examination
- 2006-05-09 US US11/382,309 patent/US20060251749A1/en not_active Abandoned
-
2009
- 2009-01-07 HK HK09100162.3A patent/HK1120743A1/xx unknown
-
2011
- 2011-03-16 US US13/049,731 patent/US20110223267A1/en not_active Abandoned
-
2015
- 2015-07-23 US US14/807,712 patent/US10905654B2/en active Active
-
2021
- 2021-02-01 US US17/164,231 patent/US20210154155A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1881839A4 (en) | 2009-05-20 |
JP5443754B2 (ja) | 2014-03-19 |
JP2008540551A (ja) | 2008-11-20 |
US20210154155A1 (en) | 2021-05-27 |
BRPI0608796A2 (pt) | 2010-01-26 |
BRPI0608796B1 (pt) | 2019-04-30 |
KR20080016609A (ko) | 2008-02-21 |
KR101802415B1 (ko) | 2017-11-28 |
HK1120743A1 (en) | 2009-04-09 |
US10905654B2 (en) | 2021-02-02 |
WO2006122160A3 (en) | 2007-02-08 |
WO2006122160A2 (en) | 2006-11-16 |
KR101431060B1 (ko) | 2014-08-21 |
US20160022602A1 (en) | 2016-01-28 |
EP1881839A2 (en) | 2008-01-30 |
CN101217968A (zh) | 2008-07-09 |
KR20160055972A (ko) | 2016-05-18 |
US20060251749A1 (en) | 2006-11-09 |
KR20130125411A (ko) | 2013-11-18 |
US20110223267A1 (en) | 2011-09-15 |
CN101217968B (zh) | 2014-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0608796B8 (pt) | método para a preparação de um extrato de planta compreendendo bacuquiol | |
BRPI1007379B8 (pt) | composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli | |
BRPI0608604B8 (pt) | moduladores de 2,3-dioxigenase de indolamina e composição farmacêutica | |
EA200870526A1 (ru) | Композиция, включающая по меньшей мере один высший алифатический спирт и экстракт griffonia simplicifolia | |
SG171649A1 (en) | Dpp iv inhibitor formulations | |
EA200970942A1 (ru) | Экстракт пажитника сенного (trigonella foenum-graecum) | |
BRPI0506751A (pt) | composições bioativas de plantas de theacea e processos para sua produção e aplicação | |
NO20060977L (no) | Mitokinon-derivater anvendt som mitokondrielle malsokende antioksidanter | |
BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
BRPI0922220A8 (pt) | Uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos | |
EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
BRPI0709581A8 (pt) | compostos de bicicloeteroarila como moduladores de px27 e seu uso | |
AR050717A1 (es) | Composiciones farmaceuticas | |
BR112012009214A2 (pt) | compostos | |
UA92636C2 (en) | Tetrahydro-pyrimidoazepines as modulators of trpv1 | |
HRP20050836A2 (en) | Polyalkene amines with improved applicational properties | |
MY138708A (en) | Biaryloxymethylarenecarboxylic acids | |
BRPI0411316A (pt) | uso de uma toxina clostrìdica para reduzir o apetite | |
BRPI0413180A (pt) | gorduras de baixo teor de ácido trans-groxo e composições de gorduras, e métodos de fazer as mesmas | |
BRPI0506493A (pt) | combinações terapêuticas | |
BRPI0512503A (pt) | composição que compreende ácido lático e lactoferrina | |
TW200716226A (en) | Compositions comprising actinidia and methods of use thereof | |
EP2257161A4 (en) | AHCY HYDROLASE INHIBITORS FOR THE TREATMENT OF HYPER-HOMOCYSEINEMIA | |
WO2006130426A3 (en) | Modulators of ccr-5 activity | |
BR0308184A (pt) | Composição oftálmica compreendendo ascomicina |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved |
Owner name: UNIGEN, INC. (US) Free format text: NOME ALTERADO DE: UNIGEN PHARMACEUTICALS, INC. |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06H | Technical and formal requirements: requirement cancelled [chapter 6.8 patent gazette] |
Free format text: O PRESENTE PEDIDO TEVE UM PARECER DE EXIGENCIA NOTIFICADO NA RPI NO 2202, DE 19/03/2013 (DESPACHO 6.6). TENDO SIDO CONSTATADO QUE A FORMULACAO DA EXIGENCIA FOI INADEQUADA, POIS A REQUERENTE JA HAVIA APRESENTADO DECLARACAO NA FORMA DO ART. 2O DA RESOLUCAO/INPI NO 207 DE 24/04/2009, REPUBLICADA COMO RESOLUCAO PR NO 69/2013, NO ATO DO DEPOSITO DO PEDIDO (DECLARACAO NEGATIVA), ANULO A REFERIDA EXIGENCIA. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/04/2019, OBSERVADAS AS CONDICOES LEGAIS. (CO) 10 (DEZ) ANOS CONTADOS A PARTIR DE 30/04/2019, OBSERVADAS AS CONDICOES LEGAIS |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/05/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |